Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.62B
Enterprise Value3.66B
P/E Ratio-21.75
PEG Ratio2.59
Price/Sales Ratio16.93
Price/Book Ratio4.51
Enterprise/Revenue17.18
Enterprise/EBITDA-34.48

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.78
Operating Margin-0.65
AD

Management Effectiveness

Return On Assets-0.15
Return On Equity-0.2

Income Statement

Revenue225.06M
Revenue/Share1.67
Gross Profit48.22M
EBITDA-138.2M
Net Income-227.34M
Diluted EPS-1.6

Balance Sheet

Total Cash195.11M
Total Cash/Share1.37
Total Debt234.37M
Total Debt/Equity0.26
Current Ratio1.38
Book Value Per Share6.35

Price History

52-Week Change20.28
52-Week High40.22
52-Week Low20.3
Moving Average 50 Days31.65
Moving Average 200 Days30.45

Statistics

Average Volume3.04M
Shares Outstanding142.05M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.03
Last Split Factor9:5
Last Split DateJune 17, 2022
AD